Journal of Hepatology
Volume 50, Issue 4 , Pages 693-704 , April 2009

Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability

  • Lukas Weseslindtner

      Affiliations

    • Clinical Institute of Virology, Medical University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria
    • ,
  • Christoph Neumann-Haefelin

      Affiliations

    • Department of Medicine II, University Freiburg, Freiburg, Germany
    • ,
  • Sergei Viazov

      Affiliations

    • Institute of Virology, Essen University Hospital, Essen, Germany
    • ,
  • Anita Haberstroh

      Affiliations

    • Department of Medicine II, University Freiburg, Freiburg, Germany
    • ,
  • Josef Kletzmayr

      Affiliations

    • Department of Medicine III, Danube Hospital, Vienna, Austria
    • ,
  • Judith H. Aberle

      Affiliations

    • Clinical Institute of Virology, Medical University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria
    • ,
  • Joerg Timm

      Affiliations

    • Institute of Virology, Essen University Hospital, Essen, Germany
    • ,
  • Stefan R. Ross

      Affiliations

    • Institute of Virology, Essen University Hospital, Essen, Germany
    • ,
  • Renate Klauser-Braun

      Affiliations

    • Department of Medicine III, Danube Hospital, Vienna, Austria
    • ,
  • Thomas F. Baumert

      Affiliations

    • Department of Medicine II, University Freiburg, Freiburg, Germany
    • INSERM Unite 748, Universite Louis Pasteur, Strasbourg, France
    • ,
  • Michael Roggendorf

      Affiliations

    • Institute of Virology, Essen University Hospital, Essen, Germany
    • ,
  • Robert Thimme

      Affiliations

    • Department of Medicine II, University Freiburg, Freiburg, Germany
    • ,
  • Heidemarie Holzmann

      Affiliations

    • Clinical Institute of Virology, Medical University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 1 40 490 79522; fax: +43 1 40 490 97 95.

Received 3 September 2008 ,Revised 6 November 2008 ,Accepted 24 November 2008.

References 

  1. Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis. 2005;9:383–398
  2. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med. 2001;194:1395–1406
  3. Tester I, Smyk-Pearson S, Wang P, Wertheimer A, Yao E, Lewinsohn DM, et al. Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med. 2005;201:1725–1731
  4. Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, Bakke A, et al. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology. 2002;35:190–198
  5. Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, Kim AY, et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 2004;127:924–936
  6. Folgori A, Spada E, Pezzanera M, Ruggeri L, Mele A, Garbuglia AR, et al. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance. Gut. 2006;55:1012–1019
  7. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA. 2002;99:15661–15668
  8. Urbani S, Amadei B, Fisicaro P, Tola D, Orlandini A, Sacchelli L, et al. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology. 2006;44:126–139
  9. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology. 1999;117:933–941
  10. Ulsenheimer A, Lucas M, Seth NP, Gerlach JT, Gruener NH, Loughry A, et al. Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses. J Viral Hepat. 2006;13:708–714
  11. Aberle JH, Formann E, Steindl-Munda P, Weseslindtner L, Gurguta C, Perstinger G, et al. Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection. J Clin Virol. 2006;36:24–31
  12. Kaplan DE, Sugimoto K, Newton K, Valiga ME, Ikeda F, Aytaman A, et al. Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C. Gastroenterology. 2007;132:654–666
  13. Zibert A, Meisel H, Kraas W, Schulz A, Jung G, Roggendorf M. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology. 1997;25:1245–1249
  14. Pestka JM, Zeisel MB, Bläser E, Schürmann P, Bartosch B, Cosset FL, et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci USA. 2007;104:6025–6030
  15. Timm J, Lauer GM, Kavanagh DG, Sheridan I, Kim AY, Lucas M, et al. CD8 epitope escape and reversion in acute HCV infection. J Exp Med. 2004;200:1593–1604
  16. Neumann-Haefelin C, McKiernan S, Ward S, Viazov S, Spangenberg HC, Killinger T, et al. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology. 2006;43:563–572
  17. Cox AL, Mosbruger T, Mao Q, Liu Z, Wang XH, Yang HC, et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med. 2005;201:1741–1752
  18. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, et al. HCV persistence and immune evasion in the absence of memory T cell help. Science. 2003;302:659–662
  19. von Hahn T, Yoon JC, Alter H, Rice CM, Rehermann B, Balfe P, et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology. 2007;132:667–678
  20. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 2000;288:339–344
  21. Ray SC, Wang YM, Laeyendecker O, Ticehurst JR, Villano SA, Thomas DL. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol. 1999;73:2938–2946
  22. Sheridan I, Pybus OG, Holmes EC, Klenerman P. High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression. J Virol. 2004;78:3447–3454
  23. Fabrizi F, Lunghi G, Ganeshan SV, Martin P, Messa P. Hepatitis C virus infection and the dialysis patient. Semin Dial. 2007;20:416–422
  24. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial. 2007;20:440–451
  25. Ankersmit HJ, Deicher R, Moser B, Teufel I, Roth G, Gerlitz S, et al. Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis. Clin Exp Immunol. 2001;125:142–148
  26. Stachowski J, Pollok M, Burrichter H, Spithaler C, Baldamus CA. Signalling via the TCR/CD3 antigen receptor complex in uremia is limited by the receptors number. Nephron. 1993;64:369–375
  27. Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med. 1984;311:496–501
  28. Rautenberg P, Teifke I, Schlegelberger T, Ullmann U. Influenza subtype-specific IgA, IgM and IgG responses in patients on hemodialysis after influenza vaccination. Infection. 1988;16:323–328
  29. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 1989;339:237–238
  30. Mizokami M, Lau JYN. Molecular evolutionary analysis. Its application in the study of hepatitis C virus. In:  Lau JYN editors. Hepatitis C protocols. Totowa: Humana Press; 1998;p. 147–158
  31. Felsenstein J. PHYLIP (Phylogenetic Inference Package). Available from: http://evolution.gs.washington.edu/phylip.html. Accessed November 2006.
  32. Neumann-Haefelin C, Timm J, Spangenberg HC, Wischniowski N, Nazarova N, Kersting N, et al. Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection. Hepatology. 2008;47:1824–1836
  33. Barth H, Schnober EK, Zhang F, Linhardt RJ, Depla E, Boson B, et al. Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol. 2006;80:10579–10590
  34. Sarobe P, Huarte E, Lasarte JJ, López-Dı´az de Cerio A, Garcı´a N, Borrás-Cuesta F, et al. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes. J Hepatol. 2001;34:321–329
  35. Wong DK, Dudley DD, Afdhal NH, Dienstag J, Rice CM, Wang L, et al. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol. 1998;160:1479–1488
  36. Wong DK, Dudley DD, Dohrenwend PB, Lauer GM, Chung RT, Thomas DL, et al. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. J Virol. 2001;75:1229–1235
  37. Koziel MJ, Wong DK, Dudley D, Houghton M, Walker BD. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis. 1997;176:859–866
  38. Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo QL, et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest. 1995;96:2311–2321
  39. Scognamiglio P, Accapezzato D, Casciaro MA, Cacciani A, Artini M, Bruno G, et al. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol. 1999;162:6681–6689
  40. Prezzi C, Casciaro MA, Francavilla V, Schiaffella E, Finocchi L, Chircu LV, et al. Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur J Immunol. 2001;31:894–906
  41. Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Rice CM, et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol. 1996;70:7092–7102
  42. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest. 1996;98:1432–1440
  43. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 2000;6:578–582
  44. Sarobe P, Jauregui JI, Lasarte JJ, Garcı´a N, Civeira MP, Borrás-Cuesta F, et al. Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment. J Hepatol. 1996;25:1–9
  45. McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, et al. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology. 2004;40:108–114
  46. Somsouk M, Lauer GM, Casson D, Terella A, Day CL, Walker BD, et al. Spontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression. Gastroenterology. 2003;124:1946–1949
  47. Lavillette D, Morice Y, Germanidis G, Donot P, Soulier A, Pagkalos E, et al. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol. 2005;79:6023–6034
  48. Girndt M. Humoral immune responses in uremia and the role of IL-10. Blood Purif. 2002;20:485–488
  49. Booth JC, Kumar U, Webster D, Monjardino J, Thomas HC. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology. 1998;27:223–227
  50. Wertheimer AM, Miner C, Lewinsohn DM, Sasaki AW, Kaufman E, Rosen HR. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology. 2003;37:577–589

☆ The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript. The underlying research reported in the study was funded by the “Hochschuljubiläumsstiftung” of the city of Vienna, Austria (Project H1802/2006).

PII: S0168-8278(09)00006-3

doi: 10.1016/j.jhep.2008.11.023

Journal of Hepatology
Volume 50, Issue 4 , Pages 693-704 , April 2009

Article Tools

* Image Usage & Resolution